Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates

References

• Parkin DM, Fernández LMG. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12:S70–80.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581–592.
   PubMed Web of Science ®Google Scholar
• Bines J, Eniu A. Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspective. Cancer 2008;113:2353–2358.
   PubMedGoogle Scholar
• Kopjar N, Milas L, Garaj-Vrhovac V, Gamulin M. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells. Clin Exp Med 2006;6:177–190.
   PubMed Web of Science ®Google Scholar
• Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:294–300.
   PubMedGoogle Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;44:1–40.
   Web of Science ®Google Scholar
• Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, Quiles JL. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 2011; 80:347–368.
   PubMedGoogle Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1–11.
   PubMed Web of Science ®Google Scholar
• Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa M, . Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients? Antioxid Redox Signal 2011;15:903–909.
   PubMedGoogle Scholar
• Fornier MN. Approved agents for metastatic breast cancer. Semin Oncol 2011;38:S3–10.
   PubMedGoogle Scholar
• Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996;56:1291–1295.
   PubMed Web of Science ®Google Scholar
• Duthie SJ, Hawdon A. DNA stability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998;12:1491–1497.
   PubMed Web of Science ®Google Scholar
• Ochoa JJ, Quiles JL, Ramirez-Tortosa MC, Mataix J, Huertas JR. Dietary oils high in oleic acid but with different unsaponifiable fraction contents have different effects in fatty acid composition and peroxidation in rabbit LDL. Nutrition 2002;18:60–65.
   PubMedGoogle Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231–1237.
   PubMed Web of Science ®Google Scholar
• Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999;20:145–157.
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185–229.
   PubMed Web of Science ®Google Scholar
• Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005;39:172–176.
   PubMed Web of Science ®Google Scholar
• Perumal SS, Shanthi P, Sachdanandam P. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria. Chem Biol Interact 2005;152:49–58.
   PubMed Web of Science ®Google Scholar
• Bhatti P, Sigurdson AJ, Thomas CB, . No evidence for differences in DNA damage assessed before and after a cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2008;17: 990–994.
   PubMedGoogle Scholar
• Colleu-Durel S, Guitton N, Nourgalieva K, . Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 2004;40:445–451.
   PubMed Web of Science ®Google Scholar
• Hussien MMI, McNulty H, Armstrong N, Johnston PG, Spence RAJ, Barnett Y. Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br J Cancer 2005;92:1524–1530.
   PubMedGoogle Scholar
• Sánchez-Suárez P, Ostrosky-Wegman P, Gallegos-Hernández F, . DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer. Mutat Res 2008;640:8–15.
   PubMed Web of Science ®Google Scholar
• Nadin SB, Vargas-Roig LM, Drago G, Ibarra J, Ciocca DR. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. Cancer Lett 2006;239:84–97.
   PubMed Web of Science ®Google Scholar
• Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int 1999;55:389–399.
   PubMed Web of Science ®Google Scholar
• Kang D, Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005;12:429–441.
   PubMed Web of Science ®Google Scholar
• , Rossner P JrTerry MB, Gammon MD, . Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 2007;11:1138–1148.
   PubMedGoogle Scholar
• Kobiela J, Kubasik-Juraniec J, Stefaniak T, . The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis. Folia Morphol (Warsz) 2003;62:341–346.
   PubMedGoogle Scholar
• Tesarová P, Kalousová M, Trnková B, . Carbonyl and oxidative stress in patients with breast cancer – is there a relation to the stage of the disease? Neoplasma 2007;54:219–224.
   PubMed Web of Science ®Google Scholar
• Look MP, Musch E. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 1994;40:8–15.
   PubMed Web of Science ®Google Scholar
• Faber M, Coudray C, Hida H, Mousseau M, Favier A. Lipid peroxidation products and trace elements status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res 1995; 47:117–123.
   PubMed Web of Science ®Google Scholar
• Jałoszyński P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 1997;385:223–233.
   PubMed Web of Science ®Google Scholar
• Blasiak J, Arabski M, Krupa R, . Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res 2004;554:139–148.
   PubMed Web of Science ®Google Scholar
• Asakawa H, Koizumi H, Koike A, . Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins. Breast Cancer Res 2010;12:R17.
   PubMed Web of Science ®Google Scholar
• Serrano MJ, Nadal R, Lorente JA, . Circulating cancer cells in division in an early breast cancer patient. Ann Oncol 2011;22:2150–2151.
   PubMedGoogle Scholar